Irritable Bowel Syndrome Trial, Recruiting NCT06719778 Sponsor: Universität Duisburg-Essen Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06719778
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old
  • You have been diagnosed with Crohn's Disease for at least 6 months
  • You have had moderate to severe symptoms that seem to be triggered by food, or symptoms similar to irritable bowel syndrome (IBS), for at least 3 months
  • Your Crohn's Disease medications have been at the same dose for at least 3 months
  • You are being admitted to the clinic for internal and integrative medicine in Bamberg for regular treatment
  • You have had a specific type of camera examination of your digestive tract (a scope procedure with a special laser technology) that showed a food-related problem with your gut lining
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You are currently experiencing a severe flare-up of your Crohn's Disease
  • You have a stoma (an artificial opening on your abdomen for waste to leave the body)
  • You have a known IgE-type allergy (a specific immune system allergy) to any of the foods tested in the procedure, including egg white, soy, milk, yeast, or wheat (confirm with trial site)
  • The scope examination showed visible inflammation in the upper part of your small intestine (duodenum)
  • You are pregnant or breastfeeding
  • You have a problem with long-term heavy alcohol or drug use
  • You have taken antibiotics in the month before the study starts
  • You have another gut condition such as coeliac disease, ulcerative colitis, or certain infections or inflammatory conditions affecting the gut or other organs such as the liver or joints
  • You have been diagnosed with cancer affecting an internal organ within the last 5 years
  • You have a severe mental health condition that would make it difficult to understand or follow the study requirements
  • You are unable to give written consent or follow the study plan
  • You have taken part in another treatment-based clinical trial in the last 30 days

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jost Langhorst, Univ. Prof. Dr. med., Universität Duisburg-Essen

Phone: 0049 951 503 11650

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universität Duisburg-Essen
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 April 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Improvement of the integrity of the duodenal intestinal barrier analyzed by confocal laser endomicroscopy (CLE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov